Compare $BIOQ vs $MCRB | Chartloom

Compare

$BIOQ vs $MCRB

Bioqual Inc · Seres Therapeutics Inc

BIOQ

Bioqual Inc

MCRB

Seres Therapeutics Inc

Compare $BIOQ vs $MCRB

Comparing Bioqual Inc and Seres Therapeutics Inc

BIOQBioqual Inc

MCRBSeres Therapeutics Inc

BIOQBioqual Inc

Market cap

$29M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.4%

YTD performance

-14.3%

52W performance

-40.0%

FCF yield

20.2%

MCRBSeres Therapeutics Inc

Market cap

$26M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-82.1%

52W performance

-86.2%

FCF yield

-195.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIOQ

MCRB

Detailed metrics comparison

BIOQ

Bioqual Inc

MCRB

Seres Therapeutics Inc

Market Cap

BIOQ$29M

MCRB$26M

Enterprise Value

BIOQ$18M

MCRB$11M

Price

BIOQ$33.00

MCRB$2.71

P/E Ratio

BIOQN/A

MCRBN/A

P/S Ratio

BIOQ0.69x

MCRB13.93x

EV/Sales

BIOQ0.43x

MCRB5.65x

EV/EBITDA

BIOQ7.55x

MCRB0.00x

P/B Ratio

BIOQ0.84x

MCRB0.85x

P/FCF Ratio

BIOQ4.95x

MCRBN/A

EV/FCF

BIOQ3.05x

MCRB-0.21x

PEG Ratio

BIOQN/A

MCRBN/A

Forward P/E (NTM)

BIOQN/A

MCRBN/A

Forward P/S (NTM)

BIOQN/A

MCRBN/A

Revenue (TTM)

BIOQ$42M

MCRB$2M

Revenue Growth (YoY)

BIOQ-19.4%

MCRBN/A

Forward Rev Growth

BIOQ0.0%

MCRB-98.0%

Gross Margin (TTM)

BIOQ7.9%

MCRB0.0%

Operating Margin (TTM)

BIOQ0.0%

MCRB0.0%

EBITDA Margin (TTM)

BIOQ-0.1%

MCRB-3971.2%

Net Margin (TTM)

BIOQ-2.9%

MCRB-1192.9%

FCF Margin (TTM)

BIOQ14.0%

MCRB-2724.1%

Net Income (TTM)

BIOQ$-1M

MCRB$-22M

FCF (TTM)

BIOQ$6M

MCRB$-51M

EPS (TTM)

BIOQ-$1.38

MCRB-$2.30

ROE (TTM)

BIOQ-346.0%

MCRB-6032.0%

ROA (TTM)

BIOQ-193.0%

MCRB-1794.0%

ROIC (TTM)

BIOQ-346.0%

MCRB-6032.0%

Cash

BIOQ$11M

MCRB$16M

Debt

BIOQ$0

MCRB$0

Net Cash/Debt

BIOQ$11M

MCRB$16M

Current Ratio (TTM)

BIOQ4.01x

MCRB2.11x

Quick Ratio (TTM)

BIOQ3.91x

MCRB2.04x

Debt/Equity (TTM)

BIOQ0.00x

MCRB0.00x

Debt/Assets (TTM)

BIOQ0.0%

MCRB0.0%

Interest Coverage (TTM)

BIOQN/A

MCRBN/A

Net Debt/EBITDA (TTM)

BIOQ0.00x

MCRB0.00x

Beta

BIOQ-0.48

MCRB0.49

52W Performance

BIOQ-40.0%

MCRB-86.2%

YTD Performance

BIOQ-14.3%

MCRB-82.1%

% from 52W High

BIOQ-69.6%

MCRB-91.0%

% from 52W Low

BIOQ1.5%

MCRB12.0%

Asset Turnover (TTM)

BIOQ0.66x

MCRB0.02x

FCF Yield (TTM)

BIOQ20.2%

MCRB-195.5%

Earnings Yield (TTM)

BIOQ-4.2%

MCRB-85.6%

Dividend Yield (TTM)

BIOQN/A

MCRBN/A

Rule of 40

BIOQ-5.4

MCRB-2,724.1

EV/GP/RG

BIOQN/A

MCRBN/A

Ticker research

View BIOQ research View MCRB research

Metric	BIOQ Bioqual Inc	MCRB Seres Therapeutics Inc
Market & Valuation
Market Cap	$29M	$26M
Enterprise Value	$18M	$11M
Price	$33.00	$2.71
P/E Ratio	N/A	N/A
P/S Ratio	0.69x	13.93x
EV/Sales	0.43x	5.65x
EV/EBITDA	7.55x	0.00x
P/B Ratio	0.84x	0.85x
P/FCF Ratio	4.95x	N/A
EV/FCF	3.05x	-0.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$42M	$2M
Revenue Growth (YoY)	-19.4%	N/A
Forward Rev Growth	0.0%	-98.0%
Profitability
Gross Margin (TTM)	7.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.1%	-3971.2%
Net Margin (TTM)	-2.9%	-1192.9%
FCF Margin (TTM)	14.0%	-2724.1%
Net Income (TTM)	$-1M	$-22M
FCF (TTM)	$6M	$-51M
EPS (TTM)	-$1.38	-$2.30
ROE (TTM)	-346.0%	-6032.0%
ROA (TTM)	-193.0%	-1794.0%
ROIC (TTM)	-346.0%	-6032.0%
Financial Health
Cash	$11M	$16M
Debt	$0	$0
Net Cash/Debt	$11M	$16M
Current Ratio (TTM)	4.01x	2.11x
Quick Ratio (TTM)	3.91x	2.04x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.48	0.49
52W Performance	-40.0%	-86.2%
YTD Performance	-14.3%	-82.1%
% from 52W High	-69.6%	-91.0%
% from 52W Low	1.5%	12.0%
Efficiency & Yields
Asset Turnover (TTM)	0.66x	0.02x
FCF Yield (TTM)	20.2%	-195.5%
Earnings Yield (TTM)	-4.2%	-85.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-5.4	-2,724.1
EV/GP/RG	N/A	N/A
Ticker research	View BIOQ research	View MCRB research

Valuation

P/S Ratio

BIOQ

0.69x

MCRB

13.93x

EV/FCF

MCRB

-0.21x

BIOQ

3.05x

Growth & revenue

Revenue Growth TTM

BIOQ

-19.4%

Forward Revenue Growth

BIOQ

0.0%

MCRB

-98.0%

Profitability & performance

Gross Margin

BIOQ

7.9%

MCRB

0.0%

ROE

BIOQ

-346.0%

MCRB

-6032.0%

FCF Yield %

BIOQ

20.2%

MCRB

-195.5%

52-Week Performance

BIOQ

-40.0%

MCRB

-86.2%

Detailed metrics comparison

BIOQ

Bioqual Inc

MCRB

Seres Therapeutics Inc

Market Cap

BIOQ$29M

MCRB$26M

Enterprise Value

BIOQ$18M

MCRB$11M

Price

BIOQ$33.00

MCRB$2.71

P/E Ratio

BIOQN/A

MCRBN/A

P/S Ratio

BIOQ0.69x

MCRB13.93x

EV/Sales

BIOQ0.43x

MCRB5.65x

EV/EBITDA

BIOQ7.55x

MCRB0.00x

P/B Ratio

BIOQ0.84x

MCRB0.85x

P/FCF Ratio

BIOQ4.95x

MCRBN/A

EV/FCF

BIOQ3.05x

MCRB-0.21x

PEG Ratio

BIOQN/A

MCRBN/A

Forward P/E (NTM)

BIOQN/A

MCRBN/A

Forward P/S (NTM)

BIOQN/A

MCRBN/A

Revenue (TTM)

BIOQ$42M

MCRB$2M

Revenue Growth (YoY)

BIOQ-19.4%

MCRBN/A

Forward Rev Growth

BIOQ0.0%

MCRB-98.0%

Gross Margin (TTM)

BIOQ7.9%

MCRB0.0%

Operating Margin (TTM)

BIOQ0.0%

MCRB0.0%

EBITDA Margin (TTM)

BIOQ-0.1%

MCRB-3971.2%

Net Margin (TTM)

BIOQ-2.9%

MCRB-1192.9%

FCF Margin (TTM)

BIOQ14.0%

MCRB-2724.1%

Net Income (TTM)

BIOQ$-1M

MCRB$-22M

FCF (TTM)

BIOQ$6M

MCRB$-51M

EPS (TTM)

BIOQ-$1.38

MCRB-$2.30

ROE (TTM)

BIOQ-346.0%

MCRB-6032.0%

ROA (TTM)

BIOQ-193.0%

MCRB-1794.0%

ROIC (TTM)

BIOQ-346.0%

MCRB-6032.0%

Cash

BIOQ$11M

MCRB$16M

Debt

BIOQ$0

MCRB$0

Net Cash/Debt

BIOQ$11M

MCRB$16M

Current Ratio (TTM)

BIOQ4.01x

MCRB2.11x

Quick Ratio (TTM)

BIOQ3.91x

MCRB2.04x

Debt/Equity (TTM)

BIOQ0.00x

MCRB0.00x

Debt/Assets (TTM)

BIOQ0.0%

MCRB0.0%

Interest Coverage (TTM)

BIOQN/A

MCRBN/A

Net Debt/EBITDA (TTM)

BIOQ0.00x

MCRB0.00x

Beta

BIOQ-0.48

MCRB0.49

52W Performance

BIOQ-40.0%

MCRB-86.2%

YTD Performance

BIOQ-14.3%

MCRB-82.1%

% from 52W High

BIOQ-69.6%

MCRB-91.0%

% from 52W Low

BIOQ1.5%

MCRB12.0%

Asset Turnover (TTM)

BIOQ0.66x

MCRB0.02x

FCF Yield (TTM)

BIOQ20.2%

MCRB-195.5%

Earnings Yield (TTM)

BIOQ-4.2%

MCRB-85.6%

Dividend Yield (TTM)

BIOQN/A

MCRBN/A

Rule of 40

BIOQ-5.4

MCRB-2,724.1

EV/GP/RG

BIOQN/A

MCRBN/A

Ticker research

View BIOQ research View MCRB research

Metric	BIOQ Bioqual Inc	MCRB Seres Therapeutics Inc
Market & Valuation
Market Cap	$29M	$26M
Enterprise Value	$18M	$11M
Price	$33.00	$2.71
P/E Ratio	N/A	N/A
P/S Ratio	0.69x	13.93x
EV/Sales	0.43x	5.65x
EV/EBITDA	7.55x	0.00x
P/B Ratio	0.84x	0.85x
P/FCF Ratio	4.95x	N/A
EV/FCF	3.05x	-0.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$42M	$2M
Revenue Growth (YoY)	-19.4%	N/A
Forward Rev Growth	0.0%	-98.0%
Profitability
Gross Margin (TTM)	7.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.1%	-3971.2%
Net Margin (TTM)	-2.9%	-1192.9%
FCF Margin (TTM)	14.0%	-2724.1%
Net Income (TTM)	$-1M	$-22M
FCF (TTM)	$6M	$-51M
EPS (TTM)	-$1.38	-$2.30
ROE (TTM)	-346.0%	-6032.0%
ROA (TTM)	-193.0%	-1794.0%
ROIC (TTM)	-346.0%	-6032.0%
Financial Health
Cash	$11M	$16M
Debt	$0	$0
Net Cash/Debt	$11M	$16M
Current Ratio (TTM)	4.01x	2.11x
Quick Ratio (TTM)	3.91x	2.04x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.48	0.49
52W Performance	-40.0%	-86.2%
YTD Performance	-14.3%	-82.1%
% from 52W High	-69.6%	-91.0%
% from 52W Low	1.5%	12.0%
Efficiency & Yields
Asset Turnover (TTM)	0.66x	0.02x
FCF Yield (TTM)	20.2%	-195.5%
Earnings Yield (TTM)	-4.2%	-85.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-5.4	-2,724.1
EV/GP/RG	N/A	N/A
Ticker research	View BIOQ research	View MCRB research